TD Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-302,724
| Closed | -$2.31M | – | 1274 |
|
|
2024
Q3 | $2.31M | Buy |
302,724
+62,124
| +26% | +$473K | ﹤0.01% | 983 |
|
|
2024
Q2 | $1.49M | Buy |
+240,600
| New | +$1.49M | ﹤0.01% | 1077 |
|
|
2016
Q1 | – | Sell |
-20,100
| Closed | -$207K | – | 1360 |
|
|
2015
Q4 | $207K | Sell |
20,100
-14,100
| -41% | -$145K | ﹤0.01% | 1306 |
|
|
2015
Q3 | $390K | Buy |
+34,200
| New | +$390K | ﹤0.01% | 1139 |
|
|
2014
Q2 | – | Sell |
-33,700
| Closed | -$357K | – | 1287 |
|
|
2014
Q1 | $357K | Buy |
+33,700
| New | +$357K | ﹤0.01% | 1115 |
|